Suppr超能文献

微小RNA在甲状腺癌中的表达

Expression of MicroRNAs in Thyroid Carcinoma.

作者信息

Zhu Gaohong, Xie Lijun, Miller Daniel

机构信息

Department of Nuclear Medicine, First Affiliated Hospital of Kunming Medical University, Kunming, Yunnan, 650032, China.

School of Computing, University of South Alabama, Mobile, AL, 36688, USA.

出版信息

Methods Mol Biol. 2017;1617:261-280. doi: 10.1007/978-1-4939-7046-9_19.

Abstract

MicroRNA (miRNA) are negative regulators of gene expression and subsequent protein production. This method of action translates into regulatory control over cellular processes, including development, signaling, metabolism, and apoptosis. A broad range of miRNA are shown to have abnormal expressions in thyroid cancers which could explain the pathology of tumor oncogenesis and disease progression. A review is conducted of the current research on miRNA dysregulation in thyroid cancers, including papillary thyroid carcinoma (PTC), follicular thyroid carcinoma (FTC), anaplastic thyroid cancer (ATC), and medullary thyroid carcinoma (MTC). Dysregulated miRNA and their associated regulatory pathways are identified and their oncogenic and pathological significance are discussed.

摘要

微小RNA(miRNA)是基因表达及后续蛋白质产生的负调控因子。这种作用方式转化为对细胞过程的调控,包括发育、信号传导、代谢和细胞凋亡。大量miRNA在甲状腺癌中呈现异常表达,这可以解释肿瘤发生和疾病进展的病理过程。本文综述了目前关于甲状腺癌(包括乳头状甲状腺癌(PTC)、滤泡状甲状腺癌(FTC)、未分化甲状腺癌(ATC)和髓样甲状腺癌(MTC))中miRNA失调的研究。确定了失调的miRNA及其相关调控途径,并讨论了它们的致癌和病理意义。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验